Kolmar BioTech, Inc. (215380.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩2,100 (+3.45%) as of
Key statistics
- Market cap
- 35.01B
- Dividend yield
- 0.00%
- 52-week range
- 1,707.00 – 4,535.00
- Beta
- 0.54
- Revenue (TTM)
- 40.3B
- Profit margin
- -9.12%
- Volume
- 23.98k
About Kolmar BioTech, Inc.
Kolmar BioTech, Inc. engages in the various research services in South Korea. The company provides LAB CLOUD, a bio-specialized accelerator and research platform; and efficacy evaluation, clinical and histopathology, general and inhalation toxicology, behavioral test, bioanalytical, organoids, ADME, NMR analysis, SPR analysis, IND package, shared lab animal facility, breeding lab, microbial and environmental monitoring, and technical support services. In addition, It offers construction and implementation, infection control, maintenance, laboratory and pharmaceutical equipment, and consumables and animal resourcing services. Kolmar BioTech, Inc. was formerly known as WOOJUNG BIO, Inc. and changed its name to Kolmar BioTech, Inc. in July 2026. The company was founded in 1989 and is based in Hwaseong-si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Hwaseong-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.